ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.431,61
0,12%
S&P 500
5.994,57
-0,76%
Dow Jones
44.421,91
-0,28%
Euro vs US Dollar
1,03336
0,06%
Bitcoin
99.338,73
-2,05%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. MeiraGTx Holdings PLC (MGTX) Börsenkurse

MeiraGTx Holdings PLC

MeiraGTx Holdings PLC (MGTX)

NASDAQ
6,13
-0,16
(-2,54%)
Geschlossen 04 Februar 10:00PM
Verzögert um 15 Minuten
6,13
0,00
( 0,00% )
Vor Marktöffnung: 10:09AM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
6,13
Gebot
2,46
Fragen
9,80
Volumen
-
0,00 Tagesbereich 0,00
3,85 52-Wochen-Bereich 7,37
Marktkapitalisierung
479,08M
Handelsende
6,13
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
273.833
Ausgegebene Aktien
78.153.401
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-5,70
Gewinn pro Aktie (EPS)
-1,08
Erlöse
14,02M
Nettogewinn
-84,03M

Über MeiraGTx Holdings PLC

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and Eu... MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and European Union. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
www.meiragtx.com
Hauptsitz
Grand Cayman, Cym
Gegründet
-
MeiraGTx Holdings PLC is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MGTX. The last closing price for MeiraGTx was US$6,13. Over the last year, MeiraGTx shares have traded in a share price range of US$ 3,85 to US$ 7,37.

MeiraGTx currently has 78.153.401 shares in issue. The market capitalisation of MeiraGTx is US$479,08 million. MeiraGTx has a price to earnings ratio (PE ratio) of -5.70.

MGTX Neueste Nachrichten

Weitere Nachrichten

MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D Mutations

LONDON and NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings Plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced the U.S...

22 Januar 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

22 Januar 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

22 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

17 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

17 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

11 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

11 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

11 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

11 Januar 2025
Edgar (US Regulatory)

Form 8-K - Current report

09 Dezember 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.05-0.8090614886736.186.5956.082061146.29801394CS
4-0.18-2.852614896996.316.665.63057496.16733875CS
12-0.96-13.54019746127.097.375.62738336.21906733CS
261.6336.22222222224.57.373.852715245.59852545CS
520.345.872193436965.797.373.852185765.47442744CS
156-7.52-55.091575091613.6515.873.491956506.48818756CS
260-13.58-68.899036022319.7124.89483.491784499.84845016CS

MGTX - Frequently Asked Questions (FAQ)

What is the current MeiraGTx share price?
The current share price of MeiraGTx is US$ 6,13
How many MeiraGTx shares are in issue?
MeiraGTx has 78.153.401 shares in issue
What is the market cap of MeiraGTx?
The market capitalisation of MeiraGTx is USD 479,08M
What is the 1 year trading range for MeiraGTx share price?
MeiraGTx has traded in the range of US$ 3,85 to US$ 7,37 during the past year
What is the PE ratio of MeiraGTx?
The price to earnings ratio of MeiraGTx is -5,7
What is the cash to sales ratio of MeiraGTx?
The cash to sales ratio of MeiraGTx is 34,17
What is the reporting currency for MeiraGTx?
MeiraGTx reports financial results in USD
What is the latest annual turnover for MeiraGTx?
The latest annual turnover of MeiraGTx is USD 14,02M
What is the latest annual profit for MeiraGTx?
The latest annual profit of MeiraGTx is USD -84,03M
What is the registered address of MeiraGTx?
The registered address for MeiraGTx is 27 HOSPITAL ROAD, GEORGE TOWN, GRAND CAYMAN
What is the MeiraGTx website address?
The website address for MeiraGTx is www.meiragtx.com
Which industry sector does MeiraGTx operate in?
MeiraGTx operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
EVAXEvaxion Biotech AS
US$ 4,07
(69,58%)
14,37M
PTIRGraniteShares 2X Long PLTR Daily ETF
US$ 212,79
(37,01%)
80,37k
PLTUDirexion DAily PLTR Bull 2X Shares
US$ 45,09
(36,68%)
114,3k
IVVDInvivyd Inc
US$ 1,34
(26,42%)
11,95M
SUGPSU Group Holdings Ltd
US$ 1,20
(21,24%)
1
UOKAMDJM Ltd
US$ 0,1685
(-29,20%)
1,05M
UPCUniverse Pharmaceuticals Inc
US$ 0,3051
(-26,90%)
113,8k
TENXTenax Therapeutics Inc
US$ 4,48
(-24,71%)
98
EJHE Home Household Service Holdings Ltd
US$ 0,7794
(-23,59%)
41,66k
MYSZMy Size Inc
US$ 1,67
(-21,23%)
276
EVAXEvaxion Biotech AS
US$ 4,07
(69,58%)
14,37M
IVVDInvivyd Inc
US$ 1,34
(26,42%)
11,95M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,1639
(-15,91%)
3,61M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0405
(-12,34%)
3,48M
PLTRPalantir Technologies Inc
US$ 99,62
(18,96%)
2,69M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
MGTX
MeiraGTx
TSXV
LKY
Lucky Minerals
TG
OE6
Ibotta
TG
BDO
Clarus
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten